Vanda Pharmaceuticals
VNDA
VNDA
179 hedge funds and large institutions have $227M invested in Vanda Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 65 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
179
Holders Change
-9
Holders Change %
-4.79%
% of All Funds
2.85%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
28
Increased
64
Reduced
65
Closed
35
Calls
$35K
Puts
$83K
Net Calls
-$48K
Net Calls Change
-$656K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$8.71M |
| 2 |
NCM
2
Nantahala Capital Management
New Canaan,
Connecticut
|
$4.32M |
| 3 |
3
D.E. Shaw & Co
New York
|
$8.41M |
| 4 |
4
Acadian Asset Management
Boston,
Massachusetts
|
$7.56M |
| 5 |
5
Morgan Stanley
New York
|
$6.87M |
